Blood 5-hydroxytryptamine, 5-hydroxyindoleacetic acid and melatonin levels in patients with either Huntington's disease or chronic brain injury.
about
The antiapoptotic activity of melatonin in neurodegenerative diseases.Adaptation to experimental jet-lag in R6/2 mice despite circadian dysrhythmia.A systems-level "misunderstanding": the plasma metabolome in Huntington's diseaseInflammatory status and kynurenine metabolism in rheumatoid arthritis treated with melatonin.A Tale of Two Maladies? Pathogenesis of Depression with and without the Huntington's Disease Gene Mutation.Hypothalamic dysfunction and neuroendocrine and metabolic alterations in Huntington's disease: clinical consequences and therapeutic implications.Delayed onset of the diurnal melatonin rise in patients with Huntington's disease.Oxidative Stress and Huntington's Disease: The Good, The Bad, and The Ugly.Understanding the neuropsychiatric consequences associated with significant traumatic brain injury.Promising Role of Melatonin as Neuroprotectant in Neurodegenerative Pathology.Are the proposed benefits of melatonin-rich foods too hard to swallow?Kynurenine Pathway in Skin Cells: Implications for UV-Induced Skin DamageNeuroprotective effect of carvedilol and melatonin on 3-nitropropionic acid-induced neurotoxicity in neuroblastoma.Plasma melatonin is reduced in Huntington's disease.A Critical Evaluation of Wet Biomarkers for Huntington's Disease: Current Status and Ways Forward.
P2860
Q33757816-4E40C229-C3D2-42C6-8FA7-4494CAD948E5Q34579980-F13B3D64-6674-4F41-8D1A-4D67D3E816BFQ35935105-2A121471-4764-4A7E-93A6-065B11F69839Q36102615-BA80B2D8-CB24-45BB-8E28-041BEBACBD49Q36993596-51AD680F-E9E8-4062-9EAC-1DE005885A1AQ37003956-30B7A6AD-1560-4C26-8EEF-C7434AE15A09Q37428690-D3CA13E9-DB7E-42AC-BA74-6EA1BC02C716Q37643688-F4AC7080-7EF3-4838-80D3-769B646FE14DQ38116068-3492F34E-0A31-45EA-A5F6-355294CEA405Q38243554-FC7178B5-95BA-4615-85B5-6E0E317B10F6Q38480886-FA63AA43-F181-4F8D-9F1B-46A20D894AD2Q42037158-698E79C0-6C66-4B73-A063-972B1482EBA7Q43179080-AAE2B80C-5D55-4D63-9F78-C469F4A4976FQ45301381-8187F8B0-0D82-40E0-91B4-42C5531DA2F8Q52721984-507FA5A6-D6D8-4FA4-A035-BBCCF224D16C
P2860
Blood 5-hydroxytryptamine, 5-hydroxyindoleacetic acid and melatonin levels in patients with either Huntington's disease or chronic brain injury.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh-hant
name
Blood 5-hydroxytryptamine, 5-h ...... sease or chronic brain injury.
@en
Blood 5-hydroxytryptamine, 5-h ...... sease or chronic brain injury.
@nl
type
label
Blood 5-hydroxytryptamine, 5-h ...... sease or chronic brain injury.
@en
Blood 5-hydroxytryptamine, 5-h ...... sease or chronic brain injury.
@nl
prefLabel
Blood 5-hydroxytryptamine, 5-h ...... sease or chronic brain injury.
@en
Blood 5-hydroxytryptamine, 5-h ...... sease or chronic brain injury.
@nl
P2093
P2860
P1476
Blood 5-hydroxytryptamine, 5-h ...... sease or chronic brain injury.
@en
P2093
Christofides J
Darlington LG
Forrest CM
P2860
P304
P356
10.1111/J.1471-4159.2006.03807.X
P407
P577
2006-03-29T00:00:00Z